AUPH — AURINIA PHARMACEUTICALS INC

Ownership history in WOLVERINE TRADING, LLC  ·  30 quarters on record

This page tracks every 13F SEC filing in which WOLVERINE TRADING, LLC reported a position in AURINIA PHARMACEUTICALS INC (AUPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 REDUCED 26,000 -54,600 -67.7% 0.00% $225K $8.47
2025 Q2 ADDED 80,600 +61,226 +316.0% 0.00% $696K $8.47
2025 Q1 REDUCED 19,374 -5,526 -22.2% 0.00% $161K $8.04
2025 Q1 REDUCED 24,900 -59,200 -70.4% 0.00% $206K $8.04
26 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    AUPH price (monthly, adj. close)

Other funds also holding AUPH

As of 2025 Q4 — sorted by position size

TANG CAPITAL MANAGEMENT LLC 3Y 7Y 8.93% KOTLER KEVIN 4.57% NEA Management Company, LLC 3Y 7Y 3.23% nVerses Capital, LLC 0.91% IRONWOOD INVESTMENT MANAGEMENT LLC 3Y 7Y 0.77% Neo Ivy Capital Management 3Y 7Y 0.58% Uniplan Investment Counsel, Inc. 3Y 7Y 0.54% PSP Research LLC 0.47% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 0.44% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.4%
← Back to WOLVERINE TRADING, LLC Holdings